Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HansaBioMed Life Sciences

HansaBioMed Life Sciences?uq=AFYHfsyn
2007 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of diagnostic services intended for testing and validating cancer and neuro-degenerative diseases. The company's diagnostic services include ultra conservative and micro filtration, size exclusion chromatography, immunoaffinity, nucleic acid isolation, enabling customers to have scientifically proven diagnosis.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Clinics/Outpatient Services
Parent Company
Primary Office
  • Akadeemia tee 15A
  • Tallinn, 12618
  • Estonia

+372 656 0000

HansaBioMed Life Sciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore HansaBioMed Life Sciences‘s full profile, request access.

Request full access to PitchBook

HansaBioMed Life Sciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000 17-May-2017 00000 00000 00 Medical Records Systems
To view this company’s complete investment and acquisition history, request access »

HansaBioMed Life Sciences Executive Team (3)

Name Title Board
Seat
Contact
Info
Antonio Chiesi MD Founder & Chief Executive Officer
Anthony Chiesi Managing Director
Silva Maasing Chief Administrative Officer